))
Season 6 Episode 2 : Molecular Testing & Targeted Treatment in Colorectal Cancer
Manage episode 397585676 series 3445704
Inhalt bereitgestellt von NCODA and Ginger Blackmon. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von NCODA and Ginger Blackmon oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
On this week’s episode of The PQI Podcast, we sit down with Makenna Smack, PharmD, BCOP, from MD Anderson, to discuss molecular testing and targeted treatment in colorectal cancer.
Makenna obtained her bachelor’s in biochemistry from Brigham Young University and Doctor of Pharmacy from Roseman University in South Jordan, Utah. After graduation, she completed her PGY1 pharmacy residency at Memorial Hermann Hospital System in Houston, Texas, and a PGY2 oncology residency at Boston Medical Center in Massachusetts.
She is board-certified by the Board of Pharmacy Specialties in Oncology Pharmacy. Makenna currently works in the Gastrointestinal (GI) Medical Oncology Clinic at MD Anderson. In this role, she is part of the multidisciplinary team overseeing the care of patients with colon, rectal, hepatobiliary, neuroendocrine, pancreatic, hepatic, and upper GI cancers. Makenna is passionate about providing effective patient education, adverse event management, and supportive care for her oncology patients. Outside of work, Makenna enjoys the snowless winters in Houston, trying new restaurants, and going to the park with her husband and son.
116 Episoden
Teilen
